Analytical Data
-
Gene name
BPY2IP1
- Application
-
Alternative Names
BPY2-interacting Protein 1; BPY2IP1; C19orf5; FLJ10669; MAP-1S; MAP1S; MAP1S light chain
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q66K74
-
Expression Region
794-1053aa
-
AA Sequence
LSDSDPVPLAPGAADSDEDTEGFGVPRHDPLPDPLKVPPPLPDPSSICMVDPEMLPPKTARQTENVSRTRKPLARPNSRAAAPKATPVAAAKTKGLAGGDRASRPLSARSEPSEKGGRAPLSRKSSTPKTATRGPSGSASSRPGVSATPPKSPVYLDLAYLPSGSSAHLVDEEFFQRVRALCYVISGQDQRKEEGMRAVLDALLASKQHWDRDLQVTLIPTFDSVAMHTWYAETHARHQALGITVLGSNSMVSMQDDAFP
-
Molecular Weight
31.7kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BPY2IP1, a protein that has garnered attention in recent years, is implicated in various cellular processes and may play a role in the immune response and cellular signaling pathways. This protein is encoded by the BPY2IP1 gene, which is found in humans and other species, highlighting its evolutionary significance. Studies suggest that BPY2IP1 may interact with key proteins involved in the regulation of cellular growth and apoptosis, making it a potential target for therapeutic interventions in diseases such as cancer and autoimmune disorders. The functional understanding of BPY2IP1, however, is still in its nascent stages, necessitating extensive research to elucidate its molecular mechanisms. Recent advancements in recombinant protein technology have facilitated the expression and purification of BPY2IP1, enabling researchers to study its biochemical properties and interactions in vitro and in vivo. Moreover, the exploration of BPY2IP1’s structural characteristics through techniques such as X-ray crystallography or NMR spectroscopy could provide insights into its function and potential as a drug target. Given the increasing interest in the role of immune modulators in disease treatment, BPY2IP1 stands out as a promising candidate for further investigation, potentially leading to novel therapeutic strategies that harness its biological functions. Overall, the study of BPY2IP1 not only contributes to our understanding of fundamental cellular processes but also opens avenues for innovative research in biomedicine.
